Chemical analysis under Good Manufacturing Practices (GMP) Standards
At IQS we offer to pharmaceutical industry a physicochemical quality control testing service under GMP regulatory framework.
MANY YEARS OF EXPERIENCE IN THE FIELD OF PHYSICO-CHEMICAL ANALYSIS IS OUR GUARANTEE
In response to bio-health sector needs, IQS offers the possibility to perform different physicochemical tests under GMP regulatory framework. Since September 2017, IQS has been certified as GMP pharmaceutical laboratory to carry out Quality Control activities (physicochemical analysis) of active ingredients, medicines and raw materials in general; related to both marketed medicines and medicines under investigation.
IQS has a total of 6 laboratories: chromatography, spectroscopy, photochemistry, electrochemistry, metal analysis and thermal analysis, which carry out quality control activities to support the industrial sector (pharmaceutical, veterinary, active ingredients, biotechnology, etc.).
SERVICES:
- Development, validation and transfer of analytical analysis
- Batch analysis for quality control
- Identification and quantification of impurities
- Quantification of active ingredients
- Determination of residual solvents
- Determination of ethylene oxide and dioxane residues
- Determination of elemental impurities or trace metals
- Identification and quantification of nitrosamines
- Analysis by DSC, TGA, IR, NMR, KF
GMP ACCREDITATION
FACILITIES
RESEARCH GROUP:
School of Engineering
Pharmaceutical Chemistry Group
The research focuses on two main areas: New Drugs in Biomedicine and Health Sciences and Flow Chemistry Processes.
School of Engineering
Electrochemistry and Bioanalysis Group
EQBA's activity is structured around the different analytical, spectrometric, chromatographic, electrochemical and optical techniques, both in their application and in their development.
LINKED NEWS
News
Analysis of nitrosamines, nitrites, and nitrates in drugs
08/01/2021
In July 2018, public health authorities became aware of the presence of the N-nitrosodimethylamine (NDMA) impurity in Valsartan batches for the first time. In the following months, other nitrosamines in drugs were detected from the same family (sartans), such as Ibersartan or Losartan, and in other drugs such as pioglitazone, ranitidine, and metformin.
READ FULL NEW
A QUOTE
CONTACT US
